Jun 18 |
Pluri: Biotech Play With Several Opportunities Across Different Sectors
|
Jun 18 |
Pluri subsidiary Ever After Foods secures $10M strategic investment
|
Jun 18 |
Pluri Subsidiary Ever After Foods Secured $10 Million Strategic Investment to Solve Cultivated Food Scalability Challenges
|
Jun 6 |
U.S. National Institutes of Health Exercises Option to Fund $1.4 Million 2nd Year Budget for Pluri’s PLX-R18 Acute Radiation Syndrome Contract
|
May 2 |
Unleashing the Power of MAIT Cells: Pluri Launches Novel Immunotherapy Platform for Solid Tumor Cancer Treatment
|
Apr 8 |
Pluri stock jumps 9% on US patent for immune cell production
|
Apr 8 |
Breakthrough in Immune Cell Expansion: Pluri Granted U.S Patent for New Method
|
Mar 27 |
Pluri to implement a 1-for-8 reverse stock split
|
Mar 27 |
Pluri Inc. Announces 1-for-8 Reverse Share Split
|
Mar 21 |
Pluri’s Sustainable Cell-Based Coffee Addresses Critical Challenges Revealed in International Coffee Organization Market Report
|